Mangaluru: Girl alleges Facebook friend of raping her, engaging to another

Bengaluru, Mar 26: Karnataka Pradesh Congress Committee (KPCC) Working President Eshwara Khandre on Thursday suggested to the State government to utilize the infrastructure available at the International Exhibition Centre on the outskirts of the City on Tumakuru Road near Nelamangala, about 15 km from here, for quarantine and treatment of people affected with the Novel Coronavirus (COVID-19) pandemic. 

In a statement here today, Mr Khandre said that the dreaded disease is spreading like wildfire and according to experts the figure may touch one Lakh in the State. 

Hence there is necessary to have adequate infrastructure found well in advance and utlise if necessity arises. The Center is built on a 57-acre land and there are sufficient space available and since it is on the outskirts of the city there is no threat of the virus spreading to the Bengaluru City.

Mangaluru, Apr 18: The residents of Thokkottu welcomed a COVID-19 patient who was cured and discharged from hospital with a standing ovation. 

The man remained in quarantine after returning from Tablighi Jammat religious gathering at Nizamuddin in Delhi. He was tested positive for COVID-19 on April 4 and was shifted to Wenlock Hospital for treatment.

After he was tested positive, a complete lockdown was announced within a 200-metre radius of the apartment where he was residing at Thokkottu.

The cured patient will have to remain quarantined at home for the next 14 days.

He has thanked the doctors, nurses and paramedical staff of Wenlock Hospital who took care of him in the hospital. 

In the meantime, 12 COVID-19 patients out of 13 have been cured and discharged from the hospital in Dakshina Kannada district.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.